Program Administration

Drs. Jeffrey Schelling, M.D. and Dr. Jeffrey Garvin, Ph.D. will function as co-Leads for the TL1 training core because they are both senior, accomplished investigators focused on basic and translational research. In addition because their training backgrounds are distinct they can provide the trainees with both the perspective of the M.D investigator as well as the Ph.D. investigator. This combination of experience will facilitate the creation of individualized training plans for trainees of either background and ultimately reduce barriers to interdisciplinary team science that often includes investigators with both training backgrounds.

Dr. Jeffrey L. Garvin, PhD

Dr. Garvin has been active in increasing minority participation in kidney research, training 6 Hispanic PhD students and 9 Hispanic postdocs and residents. Half of his PhD students and 43% of his postdocs/residents have been women. Dr. Garvin has been a member of the minority development committee of the American Physiological Society and spearheads diversity programs for Physiology and Biophysics. Dr. Garvin serves on the Departmental Graduate Education Committee and organizes the Cleveland Kidney Chalk Talks.

Dr. Jeffrey Schelling, PhD

Dr. Jeffrey Schelling (1.2 months FTE) serves as a Co-Lead of the TL1 training core and also as a Steering Committee member of the Cleveland KUH-TN. Dr. Jeff Schelling joined the CWRU faculty in 1992, where he is currently Professor of Medicine, and Nephrology Division Chief at the CWRU MetroHealth System campus since 2003. He has received continuous funding from the NIH for 25 years and his current research effort is focused on mechanisms of diabetic nephropathy. He was also an Established Investigator of the American Heart Association. Dr. Schelling has been an ad hoc member of study sections at NIH, Veterans Administration Nephrology Merit Review, National Kidney Foundation, American Heart Association, American Society of Nephrology and Juvenile Diabetes Research Foundation, and he has just completed his second term as a standing member of the NIH DDK-D Scientific Review Group. Dr. Schelling has held many key positions in the American Society of Nephrology, including the Basic Science Research Committee, Nominating Committee and Annual Meeting Program Committee. Dr. Schelling has served on the editorial boards of the American Journal of Physiology: Renal Physiology, Journal of the American Society of Nephrology, and Frontiers in Nephrology. He has been a four-time Department of Medicine Teaching award winner. His breadth of administrative and research experience qualifies him as an exemplary co-director of the TL1 research training core with a perspective of the physician-scientist.